Ansa Biotechnologies wants to usher in a new era of DNA manufacturing
“Currently the ability to compose DNA is the main bottleneck in the artificial biology market. Currently, DNA molecules are made using a thirty year-old chemical approach that has restrictions on the length of particles that can be made. The business has established an enzyme that essentially includes bases to a DNA particle.
“Currently the ability to write DNA is the primary traffic jam in the synthetic biology industry. “If it took 3 weeks to compile your code or recompile your code to make an easy modification you could never make any development in establishing software application for the computer,” Arlow stated. Currently, DNA particles are made using a thirty year-old chemical method that has limitations on the length of molecules that can be made. The business has actually developed an enzyme that essentially adds bases to a DNA molecule.”Writing is truly the traffic jam,” Arlow said.